✦ LIBER ✦

Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients

✍ Scribed by Giuseppe Pelosi; Elisabetta Schianchi; Patrizia Dell'Orto; Giulia Veronesi; Lorenzo Spaggiari; Felice Pasini; Gabriella Sozzi; Elisabeth Brambilla; Claudia Griso; Giuseppe Viale

Book ID: 106117370
Publisher: Springer
Year: 2005
Tongue: English
Weight: 301 KB
Volume: 448
Category: Article
ISSN: 1432-2307
DOI: 10.1007/s00428-005-0087-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating Cell-Free DNA in Plasma/Seru

Circulating Cell-Free DNA in Plasma/Serum of Lung Cancer Patients as a Potential Screening and Prognostic Tool

✍ Kumar, S. 📂 Article 📅 2006 🏛 American Association for Clinical Chemistry 🌐 English ⚖ 109 KB

Plasma is a better source of tumor-deriv

Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients

✍ Vallée, Audrey; Marcq, Marie; Bizieux, Acya; Kouri, Claude El; Lacroix, Hervé; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 264 KB

66PD PRELIMINARY REAL-TIME PCR EVALUATIO

66PD PRELIMINARY REAL-TIME PCR EVALUATION OF FREE-CIRCULATING PLASMA DNA IN HEALTHY INDIVIDUALS AND PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER

✍ Szpechcinski, A.; Dancewicz, M.; Jagus, P.; Polgesek, E.; Kopinski, P.; Kowalews 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Ratio of the Maximum Standardized Uptake

Ratio of the Maximum Standardized Uptake Value on FDG-PET of the Mediastinal (N2) Lymph Nodes to the Primary Tumor May Be a Universal Predictor of Nodal Malignancy in Patients With Nonsmall-Cell Lung Cancer

✍ Robert James Cerfolio; Ayesha S. Bryant 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 167 KB

OP78 EGFR mutations based on circulating

OP78 EGFR mutations based on circulating free DNA (cfDNA) in the subset of Japanese patients (pts) from IPASS (IRESSA Pan ASia Study), a Phase III study of first-line gefitinib (G) vs carboplatin/paclitaxel (C/P) in clinically selected patients with advanced non-small-cell lung cancer (NSCLC)

✍ N. Yamamoto; Y. Ichinose; Y. Nishiwaki; Y. Ohe; K. Nishio; H. Jiang; E. Duffield 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB